These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31608998)

  • 1. LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP-mediated pathway.
    Lou C; Zhao J; Gu Y; Li Q; Tang S; Wu Y; Tang J; Zhang C; Li Z; Zhang Y
    J Cell Physiol; 2020 Apr; 235(4):3928-3938. PubMed ID: 31608998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression.
    Chen X; Wang J; Xie F; Mou T; Zhong P; Hua H; Liu P; Yang Q
    Aging (Albany NY); 2020 Jul; 12(14):14452-14466. PubMed ID: 32678071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
    Liu S; Yang Y; Wang W; Pan X
    J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA
    Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
    Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
    Han Q; Li J; Xiong J; Song Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression.
    Yang X; Yang Y; Qian X; Xu X; Lv P
    Biomed J; 2022 Jun; 45(3):512-521. PubMed ID: 35715331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC01559 promotes colorectal cancer via sponging miR-1343-3p to modulate PARP1/PTEN/AKT pathway.
    Li H; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Pathol Res Pract; 2021 Aug; 224():153521. PubMed ID: 34329839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HULC augments high glucose-associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy.
    Sharma A; Chowdhury S; Mukherjee S; Chowdhury R
    Biol Cell; 2024 Sep; 116(9):e2400034. PubMed ID: 38949568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.
    Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M
    J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
    Li T; Guo T; Liu H; Jiang H; Wang Y
    Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.
    Wang Q; Ding J; Nan G; Lyu Y; Ni G
    J Cell Biochem; 2019 Oct; 120(10):16913-16920. PubMed ID: 31099044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
    Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
    J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
    Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
    Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
    Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
    J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression.
    Shen H; Zhu H; Chen Y; Shen Z; Qiu W; Qian C; Zhang J
    Cell Death Dis; 2021 Apr; 12(4):349. PubMed ID: 33824282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.
    Chen B; Li Q; Zhou Y; Wang X; Zhang Q; Wang Y; Zhuang H; Jiang X; Xiong W
    Cell Cycle; 2018; 17(16):1949-1966. PubMed ID: 30300116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway.
    Lei S; He Z; Chen T; Guo X; Zeng Z; Shen Y; Jiang J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):470. PubMed ID: 31747939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
    Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
    Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UCA1 Regulates the Growth and Metastasis of Pancreatic Cancer by Sponging miR-135a.
    Zhang X; Gao F; Zhou L; Wang H; Shi G; Tan X
    Oncol Res; 2017 Nov; 25(9):1529-1541. PubMed ID: 28315290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.